The FSA Spy market buzz – 4 April 2025
BNY Mellon IM’s conversion; Elusive libertarian investing dream; Eastspring and Vontobel on tariffs; Wisdom of Larry Fink; Has the EU finally seen sense? Price of admission and much more.
HEAD-TO-HEAD: GAM vs JP Morgan
FSA compares the GAM Star China Equity Fund and the JPM China Fund.
On a three-year basis, both funds underperformed the MSCI China index (which Morningstar uses to benchmark the funds), with the JPM fund delivering a return of 7.55% while the GAM product had a negative return of 2.23%.
The GAM fund is move vaolatile (a standard deviation of 24.79) than the JPM fund (22.31). The GAM product also has a lower Sharpe ratio, 0.06, to JPM’s 0.18.
Related Stories
Promoted Content
-
China bonds: plugging the yield gap
-
Riding the wave of alternative income amongst HNWIs in APAC
-
Despite headwinds, ESG continues to perform
-
Taking a thematic approach to harness disruption
-
M&G Episode Macro shines after tough year
-
Investors turn to real estate for alternative income
-
Fixed income – making ground in ESG as ETFs see rapid growth in AUM
-
Your Questions Answered by Federated Hermes Impact Opportunities
-
Thematic investment series: Innovative transformation cuts across “old” and “new” economy companies
-
Protected: From “FAANG” to “MAMAA” to “Magnificent 7” – what’s in a name?
